Atlas Trials

Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity

Clinical trial NCT04817904 · UNKNOWN

Trial details

NCT number
NCT04817904
Sponsor
Cairo University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cisplatin Adverse Reaction
Start date
2020-11-17
Primary completion
2021-08-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.